TP53 and neoplasm: It has been shown that TP53-mutated (TP53mut) tumors with low TMB exhibit limited T cell infiltration and divergent immune landscapes across tumor types, highlighting the need to better understand the non-lymphoid immune compartments that may shape local immune responses [12,13].